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Introduction
Carcinoma of breast is the most common cancer among
women in Pakistan.1 In Asia, Pakistan has the highest rate
of breast cancer, affecting 1 in every 9 women with an
incidence rate of 50/100,000.1 The affected women are
typically young and often present with advanced disease.
In cities like Karachi, breast cancer constitutes up to one-
third of all malignant tumours in female patients.2 Majority
of the cancer patients undergo breast surgery,
chemotherapy and radiotherapy for cancer management.
Acute postoperative pain and persistent pain are issues of
significant concerns following breast cancer treatment.
Incidence of persistent post-surgical pain (PPSP) in patients
after breast cancer surgery is 25-60%.3,4 Persistent pain can
be severe in about 2-10% of these patients.5
Among breast cancer patients, PPSP is rated as the most
troubling aspect leading to disability and psychological
distress, and it is often resistant to management.6,7
Incidence of PPSP in Pakistani patients is currently not
known. PPSP is a type of chronic neuropathic pain disorder
that can occur following breast cancer surgeries,
particularly those operations that remove tissue from the
upper outer quadrant of the breast and / or axilla due to
association with nerve fibre injury.8,9 There is no exact
definition of PPSP, but Macrae described three important
criteria for labelling a patient as having PPSP: pain that
develops after surgery; pain of at least two-month
duration; and no other causes of pain.10,11 Most authors
consider persistent pain for a duration of 3 - 6 months as
PPSP.5
PPSP after breast surgeries is typically localised to the
anterior and / or lateral chest wall, axilla, medial side of
upper arm and is said to occur when all other causes of
pain, such as infection or recurrence, have been eliminated.
The characteristics include classic features of neuropathic
pain, such as burning, tingling, shooting, stinging, stabbing
pains and hyperaesthesia.7,12 Phantom breast pain (PBP) is
another painful condition related to the operated site.13 It
is disturbing and is characterised by painful sensations in
the region of the nipple alone or involving the entire area
of the breast or the segment that has been resected.14
The current study was planned to determine the frequency
of persistent pain in patients after breast cancer surgery,
and to assess the distribution and characteristics of pain in
such patients.
Patients and Methods
The prospective observational single cohort study was
conducted at the Department of Anaesthesiology and in
the Breast Clinic of the Department of Surgery, Aga Khan
University Hospital, Karachi, from August 2016 to January
2017. After approval from the departmental and
institutional ethics review committees, the sample was
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raised approaching all adult female patients with biopsy-
proven carcinoma of breast who were scheduled for
elective definitive breast cancer surgery, both mastectomy
and conservation.
The patients were enrolled once the operative procedure
was finalised and consent for enrolment was taken in the
Breast Clinic prior to the surgery. Those who did not give
consent and patients who required re-operation on the
same side for recurrence of cancer or for any other reason
were excluded. 
Data regarding patients’ age, weight, height, chemotherapy
and / or radiotherapy received or not, number of drains
placed, any wound complication, type of breast and axillary
surgery was obtained from patient’s medical record,
interview of patients on follow-up visits and telephonic
communication with the patients. Variables were defined
and a special form was designed for data collection. All
patients were followed up for three months after surgery
and those who had persistent pain were followed up for six
months after the operation. 
Study forms were filled by one of the reserachers. Severity
of pain was determined using numerical rating scale (NRS)
from 0 to 10, where 0 = no pain and 10 = worst pain
imaginable.15,16 Score of 1-3 was taken as mild pain, 4-6 as
moderate and a 7 and beyond as severe. Patients with
persistent pain were asked about the distribution and
characteristics of pain on their follow-up visit or on
telephonic interview.
Data was analysed using SPSS 19. Frequencies and
percentages were computed for qualitative variables, while
mean and standard deviation (SD) were used to express
quantitative variables. Univariate analysis was performed
to assess PPSP in relation to age groups, body mass index
(BMI), breast surgery, axillary dissection, chemotherapy,
radiotherapy, number of drains placed and wound
complications.
Associations between pain and other factors were analysed
using chi-square or Fisher’s exact test. The level of
significance was set p<0.05. Multivariate logistic regression
models were then used and adjusted odds ratios (AOR) and
95% confidence intervals (CIs) were calculated and the
Wald χ2 test was used to test the overall significance of each
parameter.
Results
Of the 120 patients, 63(%) were aged <49 years. The overall
mean age was 50.08±12.86 and mean BMI was 28.16±5.25
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Table-1: Multivariate logistic regression analysis for possible risk factors to  predict persistent post-surgical pain at three months.
Variables Total (n=120) PPSP (n=26) UOR [95%CI] p-value AOR [95%CI] p-value
Age (Years)
≤ 49 63 18(28.6%) 5.60[1.21 - 5.99] 0.028† 10.92[1.29 – 92.0] 0.028†
50 to 59 27 6(22.2%) 4.0[0.73 - 21.84] 0.109 8.12[0.87 – 75.41] 0.066
≥60 30 2(6.7%) Ref Ref  
BMI (kg/m2)
Normal 33 07(21.2%) 1.10[0.38 - 3.23] 0.856
Overweight 48 11(22.9%) 0.96[0.31 - 2.99] 0.974 - -
Obesity 39 8(20.5%) Ref
Breast
Mastectomy 85 23(27.1) 3.97[1.11 - 4.18] 0.035† 2.20[0.33 – 14.85] 0.418
Conservation 35 3(8.6%) Ref Ref
Axilla (n=119) *
Clearance 64 18(28.1%) 2.68[1.02 - 7.02] 0.040† 0.937[0.18 - 4.72] 0.937
Sampling 55 7(12.7%) Ref Ref
Chemotherapy 
With 102 25(24.5%) 5.52[0.69 - 43.59] 0.105 2.99[0.25 –34.77] 0.382
Without 18 1(5.6%) Ref Ref
Radiotherapy 
Yes 80 17(21.3%) 0.93[0.37 - 2.32] 0.875 0.746[0.22 – 2.49] 0.635
No 40 9(22.5%) Ref Ref
Number of drains placed 
None / One 38 3(7.9%) Ref Ref
Two / Three 82 23(28%) 4.55[1.27 - 16.25] 0.02† 3.22[0.60 – 17.15] 0.171
Wound complication 
Yes 16 4(25%) 1.24[0.36 - 4.23] 0.728 - -
No 104 22(21.2%) Ref
History of operation on same breast
Yes 15 3(20%) 0.89[0.23 - 3.42] - -
No 105 23(21.9%) Ref
kg/m2. Of them, 26(21.7%) patients developed PPSP up to
three months and 17(14.2%) had it for up to six months
post-operation (Figure).
Significant risk factors were identified at three months
(Table 1) and six months (Table 2) postoperatively. 
Of the total, 85(71%) patients underwent mastectomy and
35(29%) had breast conservation. Of the 85 mastectomised
patients, 23(27%) developed persistent pain, while 3(8.5%)
patients who underwent breast conservation surgery
developed persistent pain.
Axillary clearance was done in 64(53.3%) patients, while
limited axillary dissection, like sentinel lymph node biopsy
and axillary sampling, was done in 55(45.8%). One (0.8%
patient being stage-IV did not have any axillary procedure.
Of the 64 patients in whom axillary clearance was done,
18(28%) developed persistent pain, while 7(12.7%) patients
developed persistent pain from among those who
underwent limited axillary procedure.
Of the 26(21.7%) patients who developed PPSDP, 11(42.3%)
had burning pain, 10(38.5%) had throbbing pain, 3(11.5%)
had numbness and 2(7.7%) had mixed character of pain.
Also, 21(81%) of these patients had mild pain, 3(11.3%) had
moderate pain and 2(7.7%)had severe pain at 3 months.
Overall, 5(4.16%) patients had PBP and complained of pain
in the region of the operated breast and nipple. Further,
11(42.3%) of these patients developed pain at more than
one site including axilla, chest wall, upper arm and surgical
scar area, and the majority of these patients 15(57.7%) had
pain in axilla. 
Overall, 80(66.7%) patients required radiotherapy
postoperatively, and, of them, 17(21.25%) developed PPSP.
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Figure: Patients having persistent pain with respect to follow-up (n=120).
Table-2: Multivariate logistic regression analysis for possible risk factors to predict persistent post-surgical pain at six months.
Variables Total (n=120) PPSP (n=17) UOR [95%CI] p-value AOR [95%CI] p-value
Age (Years)
≤ 49 63 13(20.6%) 3.64[0.76 – 17.30] 0.104 8.29[0.98-69.94] 0.052
50 to 59 27 02(7.4%) 1.12[0.15-8.55] 0.913 2.38[0.19-28.76] 0.493
≥60 30 02(6.7%) Ref Ref
BMI (kg/m2)
Normal 33 4(12.1%) 1.21[0.28-5.25] 0.488
Overweight 48 9(18.8%) 0.27[0.57-7.14]
Obesity 39 4(10.3%) Ref
Breast
Mastectomy 85 16(18.8%) 7.89[1.00-61.96] 0.023 3.53[0.22-55.74] 0.371
Conservation 35 1(2.9%) Ref Ref
Axilla (n=119) * n=16
Clearance 64 13(20.3%) 4.42[1.19-16.43] 0.018 1.45[0.226-9.304] 0.693
Sampling 55 3(5.5%) Ref Ref
Chemotherapy 
With 102 17(16.7%) NA 0.072 -
Without 18 0(0%)
Radiotherapy 
Yes 80 12(15%) 1.23[0.40-3.78] 0.711 1.02[0.25-4.11] 0.983
No 40 5(12.5%) Ref Ref
Number of drains placed 
None / One 38 1(2.6%) Ref Ref
Two / Three 82 16(19.5%) 8.97[1.14-70.36] 0.014 3.39[0.26-42.87] 0.344
Wound complication 
Yes 16 3(18.8%) 1.48[0.37-5.87] 0.572 -
No 104 14(13.5%) Ref
History of operation on same breast
Yes 15 2(13.3%) 0.92[0.18-4.51] 0.921 -
No 105 15(14.3%) Ref
Of the 26 patients who developed PPSP at 3 months,
17(65.4%) had radiotherapy postoperatively. Also, 7(6%)
patients who did not complain of post-surgical pain, later
developed mild burning and throbbing pain due to
radiation therapy over chest wall and axillary areas.  
Out of the 26 patients who developed PPSP, 21(80.8%)
developed mild pain that was managed with simple
analgesics, such as paracetamol and short course of non-
steroidal anti-inflammatory drugs (NSAIDS). Besides,
3(11.5%) patients developed moderate pain and 2(7.7%)
developed severe pain. These patients were managed with
multi-modal analgesics, including opioids. 
Discussion
To the best of our knowledge, the current study is the first
to have been conducted on this topic in Pakistan, while
PPSP following different surgical procedures has received
increasing recognition over the last decade.12,17,18 It is a
substantial problem that compromises patients’ quality of
life.19
In the current study, 26(21.7%) patients reported persistent
pain three months after surgery and 17(14%) of them had
persistent pain six months after surgery. Prevalence of PPSP
after breast cancer surgeries has been variably reported
from other parts of the world ranging between 25% and
60%.3,19 Juhl et al. found the prevalence to be 38.3% after
a median follow-up of three years in Denmark.20
Age <50 years was found to be an independent risk factor
for PPSP at three-month follow-up and had borderline
significance at six months after surgery in the current study.
Studies have also identified young age to be an important
risk factor for persistent pain after mastectomy.12,19,21-23 The
reasons suggested for young age to be a risk factor include
advanced disease at presentation, larger tumour size, more
extensive dissection, higher histological grade, age-related
alterations in pain perception and different psychological
thresholds.24-26 However, a study did not find these factors
to be associated with persistent pain and stated that other
factors may account for increased prevalence of persistent
pain in young patients.12
Patients who underwent mastectomy were found to have
a greater prevalence of persistent pain at three and six
months postoperatively on univariate analysis compared
to those having breast conservation procedures. However,
this was not consistent on multivariate analysis. Therefore,
this is either not an independent risk factor or the sample
size of the current study was not large enough to capture
it as an independent risk factor. Gartner et al. did not find
mastectomy to be significantly associated with pain
compared to breast conservation surgery, but patients
having had mastectomy had higher pain scores compared
to those having breast conservation procedures.8 Mejdahl
et al., however, reported a higher prevalence of persistent
pain in patients with breast conservation rather than
mastectomy.19 Anderson et al. found mastectomy to be a
weak but significant predictor for PPSP but non-significant
after adjusting for lymphoedema.21
Axillary clearance was found to be significantly associated
with PPSP compared to limited axillary intervention
(sentinel biopsy / sampling) on univariate but not on
multivariate analysis. Axillary clearance  was found to be
associated with an increased risk of PPSP by several
studies.12,20,27 Primary reason considered responsible for
this is injury to inter-costobrachial nerve during dissection
which occurs in 80-100% cases of axillary clearance, but
sufficient data to prove this is still lacking.27,28 Anderson et
al. reported that preservation of inter-costobrachial nerve
as a significant predictor for higher levels of pain following
axillary clearance. This may be due to unidentified damage
or pulling of the nerve caused during dissection.21
Prevalence of PPSP after breast cancer surgery in Pakistan
has not previously been assessed, although breast cancer
is the most common malignancy among women in this
country. It was found to be lower in our population, and
the effects of socio-cultural and ethnic factors on pain and
its expression could be one reason for this difference.29
Research has shown that cross-cultural differences are
evident in many aspects of human behaviour and
perception, including the perception of chronic pain.30
The current study has its limitations, as it was a single-
centre study with a relatively small sample size and with a
limited follow-up of 6 months. There was some delay in
reporting results of the study as the researchers involved
happened to be busy clinicians.
Multi-centre studies with larger sample sizes are required
to assess the prevalence and would further enhance our
understanding on the reasons behind this difference in
prevalence of PPSP in Pakistan. Preventive measures along
with better pain control strategies need to be identified in
order to reduce the incidence of persistent pain after breast
cancer surgeries.
Conclusion
Persistent pain following breast cancer surgeries was found
to be 21.7%. Young age, mastectomy and axillary clearance
were identified as significant risk factors. Those who
developed persistent pain reported having burning and
throbbing pain as well as numbness.
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